Mechanisms of new immunotherapy candidate explored
The Journal of Clinical Investigation has published a scientific article describing ONC201’s ability to cause intratumoural accumulation…
Browsing: ONC201
‘First in human’ trial defines safe dosage for ONC201 for solid tumours
A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients…